Charles Baker-Glenn,Daniel Jon Burdick,Mark Chambers,Bryan K. Chan,Huifen Chen,Anthony Estrada,Janet L. Gunzner-Toste,Daniel Shore,Zachary Kevin Sweeney,Shumei Wang,Guiling Zhao
申请号：
US13687437
公开号：
US08809331B2
申请日:
2012.11.28
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Specific Compounds of formula I:or pharmaceutically acceptable salts thereof,wherein m, X, R1, R2, R3, R5, R6 and R7 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
